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Resumo
Introdução: As pessoas com esquizofrenia têm um risco acrescido de mortalidade ao mesmo tempo que recebem 
menos cuidados paliativos, dos quais o planeamento antecipado de cuidados é um componente essencial. O objetivo 
desta revisão é reunir as provas disponíveis relativamente ao planeamento antecipado de cuidados em contexto paliativo 
em pessoas com esquizofrenia, os seus obstáculos e as boas práticas a serem seguidas.    
Método: Revisão sistemática da literatura qualitativa ao longo dos últimos 20 anos relativamente à utilização de 
planeamento antecipado de cuidados em cuidados paliativos ou de fim de vida em pessoas com esquizofrenia.
Resultados: Sete artigos foram incluídos na revisão. Por análise temática foram identificados cinco temas, 
nomeadamente, a capacidade de decisão em doenças mentais graves, as particularidades do planeamento antecipado 
de cuidados na pessoa com esquizofrenia, as características da esquizofrenia que afetam o planeamento antecipado dos 
cuidados, comunicação e formação, e a multidisciplinaridade e continuidade de cuidados.
Conclusão: É urgentemente necessária mais investigação nesta área. Os pacientes enfrentam obstáculos relacionados 
com a sua doença mental, desconforto e dúvida por parte dos profissionais de saúde e falta de figuras de apoio. Uma 
abordagem multidisciplinar e colaborativa, a formação e o reconhecimento da capacidade inerente dos pacientes para 
fazerem escolhas e terem discussões eficazes sobre o seu estado de saúde, facilita o processo de planeamento antecipado 
de cuidados.
Abstract
Introduction: People with schizophrenia suffer a higher risk of mortality and at the same time receive less palliative 
care, of which advance care planning is a key element. This review aims to gather available evidence regarding the use 
of advance care planning in palliative care in people with schizophrenia, its obstacles and the best practices that should 
be followed. 
Methodology: A systematic review of the literature over the past 20 years, with a qualitative focus, on the use of 
advance care plans for people with schizophrenia and in end ‑of ‑life or palliative situations. 
Results: Seven articles were included in the review. Five themes were identified from the thematic analysis, namely 
decision capacity in severe mental illness, peculiarities of advance care planning in people with schizophrenia, 
characteristics of schizophrenia that can affect advance care planning, communication and training, and 
multidisciplinarity and continuity of care.
Conclusion: More research in this area is urgently needed. Patients face obstacles related to their mental illness, 
discomfort and doubt from health professionals, and lack of supportive figures. A multidisciplinary and collaborative 
approach, training and recognition of patients’ inherent ability to make choices and to have effective discussions about 
their health status, facilitate the process of advance care planning.
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INTRODUCTION
a. Rationale for the review  ‑ theoretical and 
practical relevance
Advance care planning (ACP) can be defined as a process 
that supports patients in understanding and establishing 
goals, plans and preferences for their future, with regard to 
decisions on medical treatment and health care, compati‑
ble with their life choices and values.1 This process can be 
initiated at any stage of life, regardless of health status, and 
may include the naming of other people meaningful to the 
individual who may in the future participate, or replace the 
individual, in the decision ‑making process.2 Advance care 
planning implies discussing choices and objectives with 
health professionals, family, and caregivers, and may have 
its ideal timing when the patient’s health status worsens; 
all decisions should be recorded.3
Advance care planning can include, but goes beyond, the 
concept of the advance directive (AD), which is a docu‑
ment with legal value, defining specific orders of treatment 
and medical intervention (e.g. orders not to resuscitate).4,5
Advance care planning  is a key element of integrated pal‑
liative care provision,6 allowing the patient to decide, while 
still having the capacity to do so, on treatments and other 
future choices, including those related to his death.7 Early 
decisions avoid unnecessary end ‑of ‑life interventions and 
value individual patient choices and preferences.8,9 The re‑
spect for, and the early integration into the palliative process 
of, the wishes and choices of patients and their families is, 
together with the individual adaptation of care and the inte‑
gration of the palliative approach into health systems, one 
of the three key themes of the palliative approach identified 
by Sawatzky and colleagues in a recent literature review.10
The research we present next shows that people with 
schizophrenia receive less, and worse, palliative care com‑
pared to their peers without schizophrenia. However, the 
specific issue of advance care planning per se is often not 
directly addressed in the literature. 
Schizophrenia affects about 0.75% to 1% of the popula‑
tion.11 Recent data indicate a median lifetime prevalence 
of 7.49 per 1000 of the population suffering from primary 
psychoses.12 
Schizophrenia is a chronic, disabling and incurable disease 
that results in a decrease in the life expectancy of patients 
by as much as 10 to 20 years.13 The causes of mortality 
in these patients are suicide14 and physical diseases such 
as cancer, cardiovascular, respiratory, liver and endocrine 
diseases.15 ‑18 
These patients tend to remain on the margins of health care 
and exhibit risky behaviors such as smoking, substance 
abuse, poor diet and sedentariness.19 ‑23 
Studies show that these patients seek between two and three 
times less physical health care, have difficulty in making 
lifestyle changes, do not value their health problems and 
experience little collaboration between their mental and 
physical care providers.24 ‑27 Faced with an equivalent risk 
of cancer, patients with schizophrenia are less screened for 
cancer, die more and receive less chemotherapy, radiother‑
apy and palliative care than the general population.18, 28
The fact that they are often isolated from society and health 
services makes it difficult to identify the need for palliative 
care at the end ‑of ‑life or in the face of chronic progressive 
and disabling illness.29 Canadian studies show that these 
patients tend to die in nursing homes rather than hospital 
services, and are less likely to receive end ‑of ‑life care, be 
followed by specialists (other than their psychiatrists) or 
receive appropriate analgesia.30 
People with schizophrenia at the end ‑of ‑life are about half 
as likely to receive palliative care as other patients and are 
generally not considered fit to make advanced end ‑of ‑life 
decisions, even when in fact they are.31,32 A recent Aus‑
tralian study found that in a population of patients who 
died of cancer, only 27.5% of those with schizophrenia 
had access to community palliative care, versus 40.4% of 
those without.33
There are several factors that make it difficult for a patient 
with schizophrenia to access palliative care. Relyea et al 
mention the stigma of mental illness and the tendency to 
attribute physical symptoms to the schizophrenia, difficul‑
ties in understanding the diagnosis, difficulties in making 
decisions, social isolation of the patient, and difficulty in 
being admitted to a palliative or medical service when one 
has a mental illness.34
Factors such as being homeless, having little family or 
caregiver support, difficulties in establishing trusting rela‑
tionships with unfamiliar health professionals, and symp‑
toms of the psychotic illness can make it difficult both to 
access and to accept palliative care.35
Best practice implies the collaboration between various 
medical specialties, psychiatry, social services, and caregiv‑
ers, as well as well the early initiation of palliative care.36
Psychosocial interventions, complex pharmacological 
management, interdisciplinary and family collaboration, 
and setting of care goals are best practices identified for 
these patients.34 
The inability of these patients to make decisions in a palli‑
ative context should not be presumed. An inclusive multi‑
‑specialized approach that addresses the physical and mental 
illnesses, lifestyles, and substance use, should be used.29 
Patients with schizophrenia may be able to decide on 
analgesia and end ‑of ‑life care preferences.32,37 Foti et al32 
conclude that patients with severe mental illness generally 
choose the same options for themselves  as they would 
for others in hypothetical palliative settings, and therefore 
care planning and future options using imaginary situa‑
tions may facilitate the patient’s reflection. However, the 
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expression of these decisions by psychiatric patients is 
rare. In a study of a small group of 150 severe psychiatric 
patients, 66% of whom had schizophrenia, only 27% of 
patients had thought of advance care planning for future 
medical situations, and only 5% had discussed it with a 
doctor.37
Cai and colleagues,38 in a quantitative study of residents 
of nursing homes in the United States show that only 57% 
of residents with severe mental illness (schizophrenia and 
other psychoses and bipolar disorder) had any kind of ad‑
vanced directive, as opposed to 68% of those who did not 
have mental illness. The authors concluded that the most 
likely reason was a bias by health professionals who pre‑
sumed a basic incapacity of patients with mental illness to 
discuss these issues. 
OBJECTIVES
In view of these data, it seemed pertinent to study the use 
of advance planning of care in this population at risk. We 
pretended to identify factors that may be barriers to ad‑
vance care planning and gather indications of best practic‑
es for their use. 
STARTING POINT
What evidence is there about the use of advance care 
planning for people with schizophrenia who are at the end 
of their life, or receiving or being referred for palliative 
care, due to physical, advanced, incurable and progressive 
illness?
a. Specific objectives
To synthesize the existing evidence on the use of advance 
care planning in people with schizophrenia and in pallia‑
tive situations
To identify the obstacles that may exist to the use of ad‑
vance care planning in these patients
To identify the best practices to be followed for the use of 
advance care planning in patients with schizophrenia and 
in palliative situations
METHODS
a. Search Descriptors
A comprehensive search was conducted of the following 
databases: b ‑On, Polytechnic Institute of Castelo Branco 
Bibliographic Catalogue and Scientific Repository, Clin‑
icalKey, Cochrane Database of Systematic Reviews, Di‑
rectory of Open Access Journals – DOAJ, OAISter, Open 
Grey, Prospero, PubMed and PubMed Central, Open Ac‑
cess Scientific Repository of Portugal – RCAAP, Scopus, 
and Web of Science – all data bases, including Medline.
The b ‑On, Scopus and Web of Science databases were ac‑
cessed on the EBSCO platform through the library of the 
Polytechnic Institute of Castelo Branco (IPCB), where 
the author is a master’s degree student in palliative care. 
The PROSPERO and Cochrane databases were searched 
with the purpose of confirming if a similar review work 
existed. 
The selected articles from the database searches were also 
searched manually, and bibliographic references consid‑
ered potentially relevant were obtained. 
The search was anchored to the following three search 
terms/concepts: “Palliative care; advance care plan; 
schizophrenia”.
For each of these terms the following English language 
synonyms or equivalent terms were also added:
1. palliative care OR end ‑of ‑life care OR terminal care 
OR dying OR hospice OR end ‑of ‑life
2. advance care plan OR acp OR advance ‑care plan OR 
end ‑of ‑life plan OR terminal care plan OR end ‑of ‑life 
plan OR terminal ‑care plan
3. schizophrenia OR psychosis OR psychoses OR psy‑
chotic disorder OR schizophrenic disorder OR severe 
mental illness
The automatic search was done for the 20 ‑year period from 
1999 to 2019. In databases where it was not possible to de‑
fine the time period, the entire database was searched. An 
additional search on the Google search engine was done 
up the end of March 2020. Appendix 1 provides further 
details of the search methodology used.
d. PICOD (population, intervention, comparison, 
outcome, study design)
i. Population
Inclusion: The population of interest were adults with 
schizophrenia or related diseases such as schizoaffective 
disease or primary delusional disorders (but not dementia, 
not affective diseases, not substance related), and who 
were receiving or had indication for palliative care, or who 
were at the end of their lives (last 12 months of expected 
life) due to the presence of an advanced, incurable and 
progressive physical illness.
Exclusion: Minors under 18, psychiatric illnesses other 
than schizophrenia or related diseases.
ii. Intervention
The objective was to identify factors that influence the use 
or not of advance care planning, and the best practice for 
its use in this population.
Inclusion: Studies in which advance care planning was 
explicitly addressed in adults in end ‑of ‑life/palliative care 
and those with schizophrenia or related illnesses.
Exclusion: Studies where advance care planning is not 
explicitly addressed.
iii. Comparison
Does not apply.
iv. Outcome
Practices, processes and interventions addressing ad‑
vanced care planning in palliative care for people with 
schizophrenia; obstacles to these processes, opinions, ex‑
periences and practices of patients, caregivers and health 
professionals. 
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v. Design
The emphasis was on qualitative studies, but grey literature 
and other relevant scientific publications with a qualitative 
focus would also be considered.
f. General inclusion and exclusion criteria
Inclusion: qualitative focus studies, on adults over 18 
years of age, diagnosed with schizophrenia or diseases of 
this spectrum; in English or Portuguese. Studies or papers 
with available abstract or accessible full text.
Exclusion: all other mental illnesses. In the case of dual 
pathology, where substance dependence is the main diag‑
nosis. Studies where the palliative approach is for the men‑
tal illness itself and not because of a physical, advanced, 
incurable and progressive illness. Non ‑qualitative works or 
without a qualitative component capable of direct analysis.
g. Data Collection
After searching the databases all citations were uploaded 
to the EndNote Web programme (https://access.clarivate.
com/login?app=endnote) and duplicates and irrelevant 
results eliminated. The remaining titles and abstracts were 
sorted based on the inclusion and exclusion criteria. 
The review followed the PRISMA flowchart process 
(http://www.prisma ‑statement.org), illustrated in Fig. 1. 
The data extracted were the identification of the study/
article, the principal author, year of publication, country 
of origin, biographical characteristics of patients and di‑
agnosis, type of study, approaches identified in the use of 
advance care planning, obstacles identified to  the use of 
advance care planning, and best practices suggested for 
advance care planning.
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PubMed and PMC n=50; WoS n=82; Scopus n=86; b-On n=73; 
PROSPERO ClinicalKey n=0; Cochrane n=3; Others n=83 
(Other = RCAAP; IPCB Document Repository; OpenGrey; OAISter) 
Sc
re
en
in
g 
In
clu
de
d 
El
ig
ib
ili
ty
 
Id
en
tif
ica
tio
n 
Manual searches 
(n = 32) 
Google, bibliographic references of consulted articles 
Records after elimination of duplicates and sorting of titles 
(n = 124) 
Articles selected  
(n = 156) 
Articles excluded by the 
abstract 
(n = 116) 
Full- text articles evaluated  
(n = 40) 
Full- text articles excluded with 
reasons 
(n = 33) 
Not schizophrenia; not ACP n=5 
Not schizophrenia, not ACP, no palliative n= 1 
Not ACP n=15 
Not ACP, not palliative n= 3 
Not schizophrenia n= 3 
Not qualitative n=5 
Not ACP, not qualitative N= 1 
 Articles included in the 
systematic review 
(n = 7) 
Figure1. Flowchart based on the PRISMA model
h. Risk of bias assessment (quality assessment)
All selected papers were evaluated using the CASP 
 ‑ Critical Appraisal Skills Programme for Qualitative Re‑
search (https://casp ‑uk.net/wp ‑content/uploads/2018/01/
CASP ‑Qualitative ‑Checklist ‑2018.pdf), and CASP  ‑ Critical 
Appraisal Skills for Systematic Review (https://casp ‑uk.net/
wp ‑content/uploads/2018/01/CASP ‑Systematic ‑Review‑
‑Checklist_2018.pdf), depending on the nature of the paper. 
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We chose to evaluate non ‑systematic reviews with the 
CASP – Review, since in our opinion, even without system‑
atization, this was the most appropriate instrument to use.
Each item was rated on a scale from 0 to 20, and each was 
assigned a low (0 ‑6) medium (7 ‑13) or high (14 ‑20) quality 
score. The individual scores are presented in Appendix 2. 
We recognize as weaknesses and risk of bias in our paper 
there being a single author doing the screening, the selec‑
tion of papers and the data analysis. 
We recognize as a weakness of our study not having access 
to the EMBASE database, although this is partially miti‑
gated by the fact that the Scopus and ClinicalKey databas‑
es are from the same publisher, Elsevier, and share some 
data sources with EMBASE.
i. Data Analysis
The qualitative data was summarized using a thematic 
approach. The overarching themes were determined by 
inductive method following the analytical and careful 
reading of the selected papers and studies. 
RESULTS
a. Characteristics of studies
Seven studies29,36,39 ‑43 were selected for inclusion in the 
systematic review, whose characteristics are presented in 
Table 1. Of the 156 articles obtained by database searches 
and manual search, 40 were selected for full text analysis. 
Of these, 33 were excluded for not meeting eligibility cri‑
teria, the most frequent cause being not directly addressing 
advance care planning (n=15). See Fig. 1.
Of the seven final articles, two are systematic reviews,39,40 
two are non ‑systematic reviews,36,43 one is a qualitative 
study with thematic analysis,29 one is a mixed qualitative 
 ‑ quantitative paper41 and one is a case report.42 
Table 1. Descriptive characteristics of the articles included in the analysis
Article Country Population Main results Design Limitations CASP 
Score 
McNamara 
et al, 2018
Australia End ‑of ‑life 
schizophrenia
Vulnerable population, especially at 
the end ‑of ‑life
Social factors make end ‑of ‑life care 
difficult.
Difficulty with decisions and self‑
‑care.
Late diagnosis of palliative needs.
Need for representatives, /
caseworkers to fight for the patient.
Need for multidisciplinary 
teamwork.
They receive less and worse 
palliative care.
Qualitative 
study.
Interviews 
with 
professionals 
with 
experience of 
people with 
schizophrenia 
at end ‑of ‑life.
Located in a 
territory of 
Australia.
Small number 
of subjects 
(16). 
19
Hanan, 
Lyons, 
2020
USA Severe 
persistent 
Mental Illness
(SPMI)
Absence of a representative, 
difficulties or doubts with decision 
capacity interfere with hospice care.
Discussions on ACP should be 
early.
Systematic 
review.
18
Woods et 
al, 2008
Canada SPMI Need for more research.
Four critical areas: capacity to 
decide and ACP, access to care, care 
provision, vulnerability.
SPMI factors make care difficult.
Difficulty of palliative care 
professionals in establishing 
relationships with patients.
SPMI can make decisions and 
participate in ACP.
A consensus approach is necessary.
Systematic 
review.
Not exclusively 
schizophrenia.
18
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Article Country Population Main results Design Limitations CASP 
Score 
Shalev  et 
al, 2017
USA End ‑of ‑life 
schizophrenia
Patients do not inherently lack 
decision ‑making ability.
Difficulty in treating these patients 
can in fact increase the value of 
ACP, for medical and psychiatric 
contingencies.
ACP must be early and frequent.
Short 
qualitative 
review.
Not systematic. 15
Foti, 2003 USA Institutional 
caregivers and 
mental health 
professionals 
working with 
SPMI and 
PAC, family 
groups of SPMI 
patients
65% of stakeholders thought that 
assistance with ACP is positive for 
people with SPMI.
Increased advance directives and 
ACP completed from 1 in 344 cases 
(before the project started) to 45 in 
961 cases over the 3 years of the 
project.
Mixed 
qualitative and 
quantitative.
SPMI 
palliative care 
educational 
project.
Assessment 
of knowledge 
and training 
needs.
Located in 
an area of 
Massachusetts, 
USA.
No evaluation 
of change in all 
interventions 
No distinction 
within the 
SPMI group.
13
Toor, 2019 Canada 2 cases with 
schizoaffective 
disorder
Do not assume inability to decide.
Do not equate psychiatric 
symptoms with inability to decide.
Importance of support from mental 
health teams and relevant people 
for patients.
Adjusting times, schedules and 
space of patient consultation to 
their needs.
Qualitative 
case report.
Case report, 2 
cases.
11
Baker, 
2005
USA SPMI Lack of investigation.
Importance of addressing end ‑of‑
‑life issues in SPMI.
ACP is generally not carried out.
Non‑
‑systematic 
review.
Not exclusively 
schizophrenia.
9
b. Quality of articles
Of the seven articles, three were of medium quality, and 
four of high quality. See Table 2.
Table 2. Evaluation of the quality of selected articles
Article Type CASP Checklist Quotation Quality 
McNamara et al, 2018 Qualitative with thematic analysis CASP ‑qualitative 19 high
Hanan,  Lyons, 2020 Systematic review CASP ‑review 18 high
Woods 2008 Systematic review CASP ‑review 18 high
Shalev et al, 2017 Non ‑systematic review CASP ‑review 15 high
Foti 2003 Mixed qualitative and quantitative CASP ‑qualitative 13 medium
Toor 2019 Qualitative case report CASP ‑qualitative 11 medium
Baker 2005 Non ‑systematic review CASP ‑review 9 medium
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c. Overview of data
In ‑depth inductive analysis of the seven articles revealed 
five overarching themes relating to palliative care advance 
care planning in people with schizophrenia.
d. Decision ‑making capacity in severe mental 
illness
Issues relating to the ability of patients to decide were raised 
by four articles.36,39,40,42 All stressed that it should not be 
assumed a priori that mental illness implies an inability to 
decide, and state that this ability is generally present. Toor42 
warns of the risk of interpreting the symptoms of mental 
illness as an indication of an inability to make decisions. 
Nevertheless, the possibility of psychotic illness or its de‑
compensation, with the presence of psychotic symptoms 
hindering or preventing the ability to make decisions, is a 
concern that palliative care professionals see as an obsta‑
cle to advance care planning.36,39,40,42
The existence of a representative or decision ‑maker who 
helps the patient or eventually replaces him/her with deci‑
sions, is considered to be of the greatest utility.29,39,40 The 
absence of an advance care plan and/or representatives puts 
patients at risk of being subjected to unwanted procedures40 
and excessive invasive interventions at the end ‑of ‑life.39
A particular issue is when there are legal limitations im‑
posed on the patient with schizophrenia, which limit his or 
her decision ‑making autonomy.41
e. Characteristics of advance care planning in 
this patient population
Advance care planning must be early, repeated throughout 
the palliative process and happen before the critical phases 
of the terminal illness.36,39 
Woods40 emphasizes the use of appropriate methods and pro‑
cesses for early planning and decision making for people with 
psychotic illnesses, referring to the central work of Foti,32,37, 
40,41 using hypothetical scenarios of end ‑of ‑life situations and 
structured questionnaires to assist in decision making.
The link between early directives for psychiatric treatment 
and early directives for physical treatment in the palliative 
context is mentioned. Shalev and colleagues refer to the use‑
fulness of having advanced directives that spell out not only 
the choices of psychiatric but also physical treatments that the 
patient agrees to in the future.36 However, even when there 
are practice protocols that indicate the obligatory discussion 
of advance plans or advance directives, these discussions do 
not take place with mental patients41 and the low rate of im‑
plementation of advanced psychiatric directives corresponds 
to a low implementation of anticipated medical directives.43
The role of mental health professionals who know the pa‑
tient and have an established relationship of trust with him/
her is fundamental in palliative care planning.29,42 They 
should help patients create future care plans for both their 
mental and physical illness.43 
f. Characteristics of schizophrenia that can 
affect advance care planning
Hospitalization is often a disturbing period for patients 
with psychoses and may not be the best time to have 
discussions about advance care planning and decisions 
about the future,39 hence the importance of having these 
discussions early in the clinical course and taking advan‑
tage of periods of stability of the psychiatric illness.40
There is also (unfounded) fear among palliative care pro‑
fessionals that discussions about end ‑of ‑life situations 
may cause decompensation of the psychiatric illness.40,41
Shalev et al raise concerns that the possibility that psy‑
chotic patients may come to need physical restrictions 
or sedation in the management of decompensation of 
their disease, and this may pose ethical questions in pal‑
liative care and prevent the creation of advance plans and 
directives.36
Among the characteristics of schizophrenia that can im‑
pede advance planning are the disorganization of thinking 
that is part of the disease, especially in situations of acute 
decompensation or symptomatic chronicity,39 and the 
difficulty people with schizophrenia have in adhering to 
treatment plans and complying with medical instructions 
and appointments.40
People with schizophrenia have difficulty in establishing 
trusting relationships and therapeutic alliances, not only 
in general, but especially with new health care profession‑
als.39,40 Hence the importance of including the mental health 
team in advance care planning, who are familiar figures 
and have an established relationship with the patient.29,41 ‑43
The frequent breakdown of relations between patients 
with schizophrenia and their relatives, with the absence of 
caregivers or representatives, and social isolation, is seen 
as an obstacle to advance care planning.41 It is therefore 
essential attend to the social and cultural particularities of 
the schizophrenic patient.42
g. Communication and training
The importance of communication seems to be implicitly 
present in every article, in the issues of decision ‑making 
capacity and in the importance of having a representative, 
a family member or other caregiver involved. Its impor‑
tance in the dialogue with the patient and relevant persons 
is explicitly mentioned as a facilitator of advance care 
planning in two articles.29,42 
Foti makes the point that there is a need for effective and 
regular communication between all mental health and 
palliative care workers involved in patient care, joint case 
discussions, and the greater need for cross ‑training, with 
mental health professionals generally lacking palliative 
care training and palliative care specialists lacking mental 
health training.41
Multidisciplinarity and continued care 
The authors stress the need for mental health professionals 
who treated the patient previously to be involved in care 
planning and not to break the already ‑existing therapeutic 
relationship.41,42 The involvement of all health profession‑
als and social services should be of a collaborative nature, 
including both the patient and caregivers.29 
Multidisciplinarity implies good working relations be‑
tween palliative and mental health teams, joint case dis‑
cussion and collaboration in care planning.29,41 ‑43
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DISCUSSION
h. Data Summary
The five themes taken from the revised articles  ‑ decision 
making capacity, particular features of advance care plan‑
ning in people with schizophrenia, the impact of schiz‑
ophrenia on advance care planning, communication and 
training, multidisciplinarity and continuity of care  ‑ inform 
us what obstacles and facilitators of advance care planning 
in these patients exist, and what best practices should be 
followed. 
The identified obstacles include the preconceived ideas of 
these patients´ inabilities to make important decisions about 
treatment and not being able to understand or deal with 
information about their terminal illness. Added to this is 
the fear that emotionally charged conversations may cause 
worsening of the mental illness. Equally present is the ten‑
dency to equate psychotic symptoms with an inability to de‑
cide. However, periods of hospitalization due to worsening 
physical illness and times of worsening psychiatric illness 
are obstacles to the process of creating an advance care plan.
The absence of a representative or caregiver and the break‑
down of family relationships, are seen as fundamental ob‑
stacles to the creation of an advance care plan. The lack of 
advanced psychiatric care planning or psychiatric advance 
directives is also associated with the absence of an advance 
care plan or medical advance directives. Another obstacle 
identified is the discomfort that mental health teams feel in 
dealing with the palliative needs of their patients and, in 
parallel, the discomfort of palliative care teams in dealing 
with patients with severe mental illness. 
Patients with schizophrenia find it difficult to establish 
relationships of trust with health professionals, have diffi‑
culty in joining treatment programmes and may be subject 
to legal measures that limit their autonomy, which make it 
difficult to create an advance care plan.
Facilitating elements of advance care planning for the 
schizophrenic patient in palliative care are the early recog‑
nition that in general these patients have the same ability 
to decide about future treatments and options as any other 
patient. The existence of a representative or significant fig‑
ure for the patient is of the utmost importance, and here the 
role of the mental health team that knows the patient well 
and with whom there is a prior bond of trust, is highlighted. 
The existence of advance directives or advance planning 
for psychiatric illness, and the addressing of palliative is‑
sues by the mental health team, facilitates the creation of 
advance medical plans. The stabilization phases of mental 
illness should be used as ideal times for discussions about 
advance care planning.
Training in both palliative care and mental illness for the 
health teams treating the patient, such as joint case discus‑
sions and effective communication between all profession‑
als and specialties, facilitates discussions on palliative care 
with the patient and the creation of advance care plans.
Best practice for the schizophrenic patient in palliative 
care should include early and repeated discussion of future 
end ‑of ‑life decisions and plans, the participation of repre‑
sentatives and caregivers, and the proactive participation 
of the mental health team in discussions on advance care 
planning. 
Joint monitoring between palliative care and mental health 
professionals and maintaining the patient’s therapeutic 
link with his mental health team is desirable, as is contin‑
uous and cross ‑training between palliative care and mental 
health teams. These teams should maintain optimal work‑
ing and collaborative relationships and joint discussion of 
cases, between themselves and with the patient. 
Ideally, advance care plans should be comprehensive and 
holistic and encompass the care of both mental and phys‑
ical illnesses.
i. Limitations of the revision
Qualitative studies do not emphasize generalizing their 
data, but rather seek to identify and validate existing ideas 
and concepts in current practice.
Even so, our review contains important limitations that 
need to be considered. First, it results from small number 
of articles  ‑ seven. All of them are from English ‑speaking 
countries; one Australian, two Canadian and the rest from 
the United States, which limits the applicability of the re‑
sults to other countries, cultures and health systems. For 
example, in Portugal, the use of advanced psychiatric di‑
rectives or advance planning of psychiatric care, along the 
lines of palliative care practice, is not common practice. 
Foti’s work in this area appears in several of the articles, 
namely Hanan et al,32,37,41 Shalev et al,32, 37 and Woods et 
al32,41 There are also cross references between articles  ‑ 
Shalev et al cites Mcnamara  et al, and Toor and Woods  et 
al cite Baker. This situation causes considerable endogamy 
among the articles that should advise caution to the reader. 
The dearth of studies dedicated to patients with schizo‑
phrenia means that only two of our seven articles deal 
exclusively with schizophrenia.29,36 Toor described two 
patients with chronic schizoaffective disorder, who nev‑
ertheless have a very similar disorder. The remaining four 
articles dealt with patients with severe persistent mental 
illness (SPMI), a definition that encompasses several pa‑
thologies. However, in all the articles there was specific 
mention of including people with schizophrenia in their 
SPMI definition, and it was possible to assess the authors’ 
specific findings pertaining to these patients, giving us 
some confidence in our analysis. It is estimated that 90% 
of patients classified as SPMI have schizophrenia.44
j. Implications for future research
Qualitative research on care planning for schizophrenic 
and palliative patients is very scarce. It seems urgent to us 
that this area be investigated, both to determine the most 
appropriate processes to make advance care planning the 
norm for this population, and to identify the obstacles and 
facilitators to this goal. Generally, advance care planning 
for these patients is approached only indirectly in the liter‑
ature, through considerations of decision ‑making capacity. 
However, there is a lack of studies directed at process 
factors, obstacles, facilitators, and best practices to be ad‑
opted, specific to early planning of care for the end ‑of ‑life 
patient with schizophrenia.
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It is important to investigate the role of mental health 
professionals at this stage of their patients’ lives, so that 
there is no breakdown in the therapeutic relationship, as 
they may be the ones in the best position to initiate the 
care planning process. It is necessary to investigate how to 
cross ‑train mental health and palliative care teams to best 
deal with these patients. 
It should be a priority to include people with psychiatric 
illnesses, particularly schizophrenia, whether or not they 
be in a palliative situation, in investigations, and to hear 
what their needs and difficulties are.
Although the diseases included in the group of severe per‑
sistent mental illness have many clinical similarities among 
themselves,45,46 it is still a heterogenous group in which 
joint analysis may not be appropriate.47 The definition of 
SPMI is highly dependent on the degree of dysfunction 
and duration of the disease46,48 rather than disease type,, 
Estimating the number of adults with severe and persistent 
mental illness who have complex`, multi ‑agency needs} 
and may not take adequate account of the clinical and psy‑
chological specificities of the person with schizophrenia 
with respect to an end ‑of ‑life and palliative care situation. 
We believe that there is a need for research aimed exclu‑
sively at patients with schizophrenia.
CONCLUSION
Advance planning of care for patients with schizophrenia 
and palliative care needs faces obstacles resulting from 
the characteristics of mental illness, social and relational 
factors, and difficulties of health professionals in dealing 
with these patients. Mental health professionals may be in 
a privileged position to initiate and facilitate this whole 
process. There is an urgent need for training and collabora‑
tion between all professionals who accompany the patient 
in this phase of life, and to not neglect this fundamental 
element of quality palliative care provision. 
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